Sensitivity analysis excluding one trial that exclusively enrolling patients with long-segment disease (≥ 15 cm) revealed a borderline significant improvement in 1-year freedom from CD-TLR with DCB+stent (RR = 0.95; 95% CI: 0.91-1.00; I2=0%).
← all excerpts
Drug-coated balloon combined with stent versus stent alone for femoropopliteal disease: a systematic review and meta-analysis.
1
—
—